Newsbenzinga
Novocure Says Optune Pax Receives CE Mark For Treatment Of Adult Patients With Locally Advanced Pancreatic Cancer Of Exocrine Origin, Concomitant With Gem/Nab-Pac
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…